-Reuters Interview
Mizuho Maintains Buy on Exelon, Lowers Price Target to $39
Mizuho analyst Paul Fremont maintains Exelon (NASDAQ:EXC) with a Buy and lowers the price target from $47 to $39.
GE CEO Culp Says Supply Chain Continues To Be A Challenge
-Reuters Interview
Related Posts
Hain Celestial Group FY2024 Adj. EBITDA Guidance of $155M – $165M
FISCAL 2024 GUIDANCE**
"We view fiscal 2024 as an inflection point, where we expect to strengthen our foundation and return to top line growth," said Chris Bellairs, Chief Financial Officer.
$1000 Invested In Hartford Finl Servs Gr 15 Years Ago Would Be Worth This Much Today
Hartford Finl Servs Gr (NYSE:HIG) has outperformed the market over the past 15 years by 2.39% on an…
Why Calidi Biotherapeutics (CLDI) Stock Is Getting Hammered
Calidi Biotherapeutics shares are trading lower by 30.7% during Friday's session. The company announced a definitive agreement for the immediate exercise of certain warrants.